Combination of Idasanutlin, Venetoclax and Obinutuzumab in Patients with Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Results from a Phase I/II Study
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Manali Kamdar, Bradley Augustson, Young Rok Do, James Edwards, Mark Hertzberg, Amanda Johnston, Jin Seok Kim, Frank P. Kroschinsky, Sonali M. Smith, Don A. Stevens, Annabelle Monnet, Ye Zhao, Yann Nouet, Viktoriya Marinova
Institutions: University of Colorado Cancer Center, Linear Clinical Research, Keimyung University Dongsan Hospital, Christchurch Hospital, Prince of Wales Hospital, Westmead Hospital, Yonsei University, Severance Hospital, University Hospital Carl Gustav Carus, University of Chicago Medical Center, Norton Healthcare, F. Hoffmann-La Roche AG
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095121398